IRCT20200727048226N1尚未招募2 期
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary artery
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •non-diabetic patients with PPCI on LAD that are SVD: non-diabetic patients definition: 1-HbA1C<6.5 2-history of non-diabetes 3-twice FBS<100 if two of three of these exist patient is eligible for entery of trial
排除标准
- •1-History of serious hypersensitivity to empagliflozin or any component of the formulation; -Severe renal impairment (eGFR <30 mL/minute/1.73 m2), end-stage renal disease (ESRD), or dialysis 2-patients that have more than one vessel disease or have SVD with non-culprit lesion >70% or with SVD of LCX or RCA 3-patients 4- diabetic patients
研究者
相似试验
进行中（未招募）
1 期
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarctionEUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
进行中（未招募）
1 期
Effect of Empagliflozin on Cardiac Output in Patients with Acute Heart Failure (EMPA Acute Heart Failure)EUCTR2017-002695-45-DERWTH Aachen University represented by the Rector, himself, represented by the Dean of the Medical Faculty50
已完成
不适用
Effect of Empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: Multi-Center placebo-controlled Double-Blind Randomized TrialType 2 diabetes with acute myocardial infarctionJPRN-UMIN000030158ippon Medical School Hospital98
已完成
4 期
Empagliflozin and its effect on heart failure in type 2 diabetesE11I50.9Type 2 diabetes mellitusHeart failure, unspecifiedDRKS00009894niversitätsklinikum Freiburg Abteilung Endokrinologie und Diabetologie72
进行中（未招募）
1 期
Empagliflozin and its effect on heart failure in type 2 diabetesEUCTR2016-000214-30-DEniversitätsklinikum Freiburg270